184 related articles for article (PubMed ID: 19506525)
1. Beneficial effects of telmisartan on left ventricular structure and function in patients with hypertension determined by two-dimensional strain imaging.
Mizuguchi Y; Oishi Y; Miyoshi H; Iuchi A; Nagase N; Oki T
J Hypertens; 2009 Sep; 27(9):1892-9. PubMed ID: 19506525
[TBL] [Abstract][Full Text] [Related]
2. Possible mechanisms of left ventricular torsion evaluated by cardioreparative effects of telmisartan in patients with hypertension.
Mizuguchi Y; Oishi Y; Miyoshi H; Iuchi A; Nagase N; Ara N; Oki T
Eur J Echocardiogr; 2010 Sep; 11(8):690-7. PubMed ID: 20382977
[TBL] [Abstract][Full Text] [Related]
3. Telmisartan improves morphologic and functional changes in both left ventricular myocardium and carotid arterial wall in patients with hypertension: assessment by tissue Doppler imaging and carotid ultrasonography.
Mizuguchi Y; Oishi Y; Miyoshi H; Iuchi A; Nagase N; Oki T
Echocardiography; 2010 Aug; 27(7):864-72. PubMed ID: 20456478
[TBL] [Abstract][Full Text] [Related]
4. Influence of regression of left ventricular hypertrophy on left atrial size and function in patients with moderate hypertension.
Mattioli AV; Bonatti S; Monopoli D; Zennaro M; Mattioli G
Blood Press; 2005; 14(5):273-8. PubMed ID: 16257872
[TBL] [Abstract][Full Text] [Related]
5. The functional role of longitudinal, circumferential, and radial myocardial deformation for regulating the early impairment of left ventricular contraction and relaxation in patients with cardiovascular risk factors: a study with two-dimensional strain imaging.
Mizuguchi Y; Oishi Y; Miyoshi H; Iuchi A; Nagase N; Oki T
J Am Soc Echocardiogr; 2008 Oct; 21(10):1138-44. PubMed ID: 18926389
[TBL] [Abstract][Full Text] [Related]
6. Concentric left ventricular hypertrophy brings deterioration of systolic longitudinal, circumferential, and radial myocardial deformation in hypertensive patients with preserved left ventricular pump function.
Mizuguchi Y; Oishi Y; Miyoshi H; Iuchi A; Nagase N; Oki T
J Cardiol; 2010 Jan; 55(1):23-33. PubMed ID: 20122545
[TBL] [Abstract][Full Text] [Related]
7. Ventricular and vascular remodelling effects of the angiotensin II receptor blocker telmisartan and/or the angiotensin-converting enzyme inhibitor ramipril in hypertensive patients.
Petrovic I; Petrovic D; Vukovic N; Zivanovic B; Dragicevic J; Vasiljevic Z; Babic R
J Int Med Res; 2005; 33 Suppl 1():39A-49A. PubMed ID: 16222899
[TBL] [Abstract][Full Text] [Related]
8. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
[TBL] [Abstract][Full Text] [Related]
9. Regression of left ventricular hypertrophy and improvement of diastolic function in hypertensive patients treated with telmisartan.
Mattioli AV; Zennaro M; Bonatti S; Bonetti L; Mattioli G
Int J Cardiol; 2004 Dec; 97(3):383-8. PubMed ID: 15561322
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular mass and mechanics in mild-to-moderate hypertension: effect of nebivolol versus telmisartan.
Fountoulaki K; Dimopoulos V; Giannakoulis J; Zintzaras E; Triposkiadis F
Am J Hypertens; 2005 Feb; 18(2 Pt 1):171-7. PubMed ID: 15752943
[TBL] [Abstract][Full Text] [Related]
11. [Antihypertensive and organ-protective action of a 36-week monotherapy with telmisartan in hypertensive patients].
Petriĭ VV; Sergushkina NG; Brazhnik VA; Makolkin VI
Ter Arkh; 2008; 80(12):13-6. PubMed ID: 19227900
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study.
Galzerano D; Tammaro P; del Viscovo L; Lama D; Galzerano A; Breglio R; Tuccillo B; Paolisso G; Capogrosso P
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1563-9. PubMed ID: 16364826
[TBL] [Abstract][Full Text] [Related]
13. Telmisartan in the treatment of hypertension in patients with chronic renal insufficiency.
Weinbergová O; Metelka R; Vymetal J; Konecný K; Kosatíková Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2004 Jul; 148(1):69-73. PubMed ID: 15523550
[TBL] [Abstract][Full Text] [Related]
14. Telmisartan 80 mg/hydrochlorothiazide 25 mg provides clinically relevant blood pressure reductions across baseline blood pressures.
Neldam S; Schumacher H; Guthrie R
Adv Ther; 2012 Apr; 29(4):327-38. PubMed ID: 22477543
[TBL] [Abstract][Full Text] [Related]
15. Impact of azelnidipine and amlodipine on left ventricular mass and longitudinal function in hypertensive patients with left ventricular hypertrophy.
Motoki H; Koyama J; Izawa A; Tomita T; Miyashita Y; Takahashi M; Ikeda U
Echocardiography; 2014 Nov; 31(10):1230-8. PubMed ID: 24645985
[TBL] [Abstract][Full Text] [Related]
16. The effects of simvastatin on left ventricular hypertrophy and left ventricular function in patients with essential hypertension.
Pan XD; Zeng ZH; Liang LY; Luo JD; Xiao AY; Lai Q; Wen YH; Lu DF; Wang W; He ZC; He WK
Clin Exp Hypertens; 2011; 33(8):558-64. PubMed ID: 21957976
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements.
Nishimura T; Hashimoto J; Ohkubo T; Kikuya M; Metoki H; Asayama K; Totsune K; Imai Y
Clin Exp Hypertens; 2005 Aug; 27(6):477-89. PubMed ID: 16081340
[TBL] [Abstract][Full Text] [Related]
18. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
Ucciferri C; Falasca K; Mancino P; Di Iorio A; Vecchiet J
Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876
[TBL] [Abstract][Full Text] [Related]
19. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of benazepril on ambulatory blood pressure, left ventricular mass, diastolic filling and aortic flow in essential hypertension.
Porcellati C; Verdecchia P; Schillaci G; Boldrini F; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):187-97. PubMed ID: 1830037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
